In Vivo Antithrombotic Effects of a Nitric Oxide-Releasing Aspirin Derivative, NCX-4016
- 1 January 1999
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 93 (1) , 43-50
- https://doi.org/10.1016/s0049-3848(98)00134-0
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Effects of very low doses of aspirin (ASA) on gastric, duodenal & rectal prostaglandins(PGs) & mucosal injuryGastroenterology, 1995
- Novel nonsterodial anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the ratPublished by Elsevier ,1994
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- A diclofenac derivative without ulcerogenic propertiesEuropean Journal of Pharmacology, 1994
- Swedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic eventsThe Lancet, 1991
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- The Effect of Chronic Aspirin Use on Duodenal and Gastric Ulcer HospitalizationsJournal of Clinical Gastroenterology, 1990
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Low dose aspirin and inhibition of thromboxane B2 production in healthy subjectsThrombosis Research, 1980
- Acetylation of prostaglandin synthase by aspirin.Proceedings of the National Academy of Sciences, 1975